Microbial proteins and cellular components

Microbial proteins and cellular components is a broad, non-specific term encompassing the various molecular structures and metabolic pathways within pathogens—including bacteria, viruses, fungi, and parasites—that serve as sites for drug action (Kohanski et al., 2010). These components include essential enzymes like DNA gyrase, structural elements such as peptidoglycan in cell walls, and the protein-synthesizing machinery of the ribosome (Walsh, 2003). In infectious diseases, these elements are vital for the pathogen's life cycle, and their disruption by antimicrobial drugs is the basis of anti-infective therapy (Akira et al., 2006). For instance, antibiotics like penicillins target cell wall synthesis, while antivirals may target viral proteases or polymerases (StatPearls, 2023). While these components are the foundation of antimicrobial pharmacology, the term itself is too heterogeneous to be classified as a single therapeutic target (NIH, 2021). Furthermore, the continuous evolution of these microbial components is the primary driver of antimicrobial resistance, necessitating the ongoing development of new drugs (WHO, 2023).

Other names

Microbial antigensPathogen-associated molecular patternsPAMPsMicrobial structural componentsBacterial componentsViral componentsMicrobial targetsPathogen components

Antimicrobial drugs exert their effects by binding to specific microbial proteins or components, thereby inhibiting essential processes such as cell wall synthesis, protein translation, or nucleic acid replication (Kohanski et al., 2010).